NFL Alumni Org Taps Pharma Traceability Technology for Member Outreach and Engagement

Track My Way platform provides data for ambassador and chapter membership campaigns.

Attilio Bellman, Director of Business Strategy for Antares Vision; Andrew Pietrangelo, President. North America for Antares Vision; Beasley Reece, CEO of NFLA; and Bart Oates, President of NFLA.
Attilio Bellman, Director of Business Strategy for Antares Vision; Andrew Pietrangelo, President. North America for Antares Vision; Beasley Reece, CEO of NFLA; and Bart Oates, President of NFLA.

Founded in 1967 by a small group of retired NFL players, NFLA is the oldest and most well-known retired player organization in professional sports. Among its 20,000 members are thousands of retired players, coaches, front office executives, spouses, cheerleaders, and avid fans.

 With so many members and key charitable initiatives, the NFLA needed a robust traceability system for enhancing new membership outreach efforts and expanding its engagement capabilities. The association selected Track My Way from Antares Vision, global supplier of inspection systems, track-and-trace technology and smart data management.

For the NFLA, the Track My Way platform provides data-driven insight into ambassador and chapter membership campaigns and “enables new avenues of digital communication for promoting organization events and initiatives to current and potential members,” according to Antares.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?